News & Events
Discovering how immune cells get into the brain in MS
Study reveals important mechanism that allows immune cells to attack myelin in MS
MS Australia publishes first report on MS Specialist Nurses in Australia
A major investigation into the critical role of MS Specialist Nurses in Australia could support MS Australia’s…
Art University redecorates facilities of Brazilian MS Association
Students and staff from "Universidade Futura do Pintor" renovated the facilities as part of a partnership between…
Leading Belgian politician presents 2017 “MS@Work” awards
Belgium’s Deputy Prime Minister, Kris Peeters, presented eight companies with awards to recognise their commitment to hiring…
2017 McDonald Fellowship and Du Pré grant recipients announced
MSIF is proud to announce the recipients of the 2017 McDonald fellowships and Du Pre grants
Portuguese MS Society (SPEM) launches new Support Line service
New Support Line will provide information and support, as well as jobs for people living with MS
European Medicines Agency recommends market authorisation for ocrelizumab (Ocrevus) in EU
The EMA has recommended that ocrelizumab (Ocrevus), the first disease-modifying treatment for primary progressive MS (PPMS), be…
Using Data to individualise patient treatments
Scientists have been using a large database to develop algorithms to predict individual responses to a particular…
A new potential biomarker for the diagnosis of MS
A new small study has discovered molecules in the blood that are specific to people with MS,…
Electric stimulation may help manage MS related fatigue
Researchers have been trialling low current electric brain stimulation as a way to help manage MS related…
Anti-histamine trial shows myelin repair possible
Anti-histamine drug clemastine may boost myelin repair in MS
MSIF visits Saudi Arabia to launch new country-focused programme
MSIF’s Capacity Building Manager visits Arfa MS Society to launch MSIF’s new country-focused programme in the Kingdom…